Outside of innovation through science, we often don’t realize that
innovation can take form beyond just a medicine or a type of therapy.
One of the things that is so unique about Novo Nordisk is how we
expand health awareness through our partnerships in the community. For
example, we are a founding sponsor of the Know
Diabetes By Heart™ initiative which is run by a collaboration
between the American Heart Association and American Diabetes Association.
With cardiovascular disease being a leading cause of death for
people living with type 2 diabetes (Source),
this initiative seeks to comprehensively and holistically combat the
national public health impact of these conditions. We place emphasis
on establishing an understanding of the link between type 2 diabetes
and cardiovascular disease among patients, supporting healthcare
providers with the latest clinical guidelines and science, and
engaging health systems to improve quality of care.
Another way our company works to elevate awareness in our
communities about the impact of the connection between type 2 diabetes
and cardiovascular risk is through our Get Real About Diabetes
Program. Through improving knowledge of the associated risks and
creating resources that guide patients in facilitating the right
conversations with their doctors, we really hope these programs help
patients to take ownership of their health.
From innovating new therapies to expanding into new disease areas,
I hope Novo Nordisk continues to innovate for the next 100 years.
Hopefully, we will all see a future soon where patients have more
options at their disposal to live longer, healthier lives.